RxDoctor Payments Data

May Nour, MD

Vascular Neurology · Los Angeles, CANPI 1366679508

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $20,009 of the $32,081 with a category attached, or 62.4%. 12 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 52.3% of the total.

$32,081in general payments, 2019–2025

Across 73 payments — averaging $439.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$17K
  • Samsung HME America, Inc.$6K
  • Astrazeneca AB$3K
  • Medtronic$2K
  • Bayer$1K
  • Balt USA, LLC$557
  • plus $1K from 6 others
$61,850in research payments, 2019–2025

Across 1 payment — averaging $61,850 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ceribell, Inc.$62K

What the payments were for

  • Consulting fees$6,98822%
  • Speaking & faculty fees$1,5005%
  • Travel & lodging$20,00962%
  • Food & beverage$3,58411%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Siemens Medical Solutions USA, Inc.24$16,790
Samsung HME America, Inc.6$6,474
Astrazeneca AB3$2,954
Medtronic(2 entities)14$2,498
Bayer1$1,309
Balt USA, LLC3$557
Stryker8$453
Johnson & Johnson5$384
Phenox Inc.2$231
AstraZeneca3$197
Microvention, Inc.2$193
Penumbra, Inc.2$41

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,081 in reported general payments places this provider in the 80th percentile of 58 vascular neurology providers in California.

See all vascular neurology providers in California

Medicare billing

Part B allowed, 2024
$49,773
Medicare patients
102
Services billed
249

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular neurology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →